Dr James Januzzi from Massachusetts General Hospital discusses the new consensus statement on heart failure, biomarker testing for diagnosing heart failure, and potential future treatments.
In this Q&A, Kevin Stewart from the American Lung Association of the Mid-Atlantic answers our questions about the new State of the Air 2018 report.
Consultant360 recently spoke with Wesley O’Neal, MD, regarding his latest research about the link between provider specialty, anticoagulation prescription patterns, and stroke risk in patients with atrial...
The Dermatologist spoke with Zelma C. Chiesa Fuxench, MD, MSCE, about her involvement with the upcoming 2018 Interdisciplinary Autoimmune Summit (IAS) and advances in atopic dermatitis (AD) research. She is...
<p>Dr Thomas Seck from Boehringer Ingelheim Pharmaceuticals discusses the EMPERIAL trials, which aim to expand the use of empagliflozin for heart failure.</p>
The American Lung Association’s Lung Force Expo aimed to educate health care providers, patients, and caregivers about lung disease, the number one killer of men and women in the United States.